Biotium launches line of exosome detection antibodies

By staff writers

July 18, 2022 -- Biotium has released a new line of antibodies for detecting exosomes called ExoBrite Antibody Conjugates.

The antibodies were designed to identify exosome markers CD9, CD63, and CD81 in isolated exosomes or exosome extracts, and are available in both cytometry and western blotting formulations, according to the firm.

Exosomes are increasingly being studied for their role in cell communication and as potential targets for drug delivery applications, the company said. ExoBrite Flow Antibodies are available in four conjugates:

  • ExoBrite 410/450
  • ExoBrite 490/515
  • ExoBrite 560/585
  • ExoBrite R-PE

They are also available in two near-infrared dyes, ExoBrite 680/700 and ExoBrite 770/800, Biotium said.

Bio-Techne touts study with ExoDx prostate test
Bio-Techne is touting a new clinical study that indicates that its exosome-based, noninvasive urine prostate test, ExoDx Prostate test (EPI), correlates...
New HPV saliva test may speed detection of mouth, throat cancers
Scientists have fused acoustics and microfluidics in a novel saliva test designed to show within minutes whether a person has a high-risk strain of HPV...
Bio-Techne's prostate cancer test lands FDA breakthrough status
Bio-Techne's ExoDx Prostate IntelliScore liquid biopsy test for spotting aggressive prostate cancers has received the U.S. Food and Drug Administration's...

Copyright © 2022

Last Updated mp 7/18/2022 1:44:36 PM